NCT01771848View on ClinicalTrials.gov

Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions

Malaria

Interventions

BIOLOGICAL

PfSPZ Challenge

Aseptic, purified, vialed, cryopreserved fully infectious NF54 P. falciparum sporozoites

Trial Locations (2)

08025

Centre d'Investigació del Medicament Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona

08036

CRESIB, Hospital Clínic-Universitat de Barcelona, Barcelona

All Listed Sponsors

collaborator

Barcelona Centre for International Health Research

OTHER

lead

Sanaria Inc.

INDUSTRY

NCT01771848 - Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults | Biotech Hunter | Biotech Hunter